Having no approved vaccine or drugs for the treatment of COVID-19 augments the severity of the disease. So how are medical professionals around the world treating the deadly COVID-19? Repurposing the drugs already approved for other disorders, remains the key approach so far.
Understanding the human coronavirus-19 disease A broad range of vaccines, monoclonal antibodies, oligonucleotide-based therapies, peptides, interferon therapies, and small-molecule drugs are underscan for the treatment of COVID-19. While the world struggles daily with a sharp rise in cases, a thorough examination of the emerging drugs’ safety and efficacy may take considerable time. Therefore, repurposing the existing antiviral drugs that have been effective against human coronaviruses related to severe acute respiratory syndrome (SARS) and Middle East Respiratory Syndrome (MERS) is the most sought out approach.…
